165 related articles for article (PubMed ID: 37605453)
1. Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer.
Sun Y; Chen Y; Zhuang W; Fang S; Chen Q; Lian M; Lv C; Weng J; Wei R; Lin Y; Cai L; Wang Q
J Cell Mol Med; 2023 Nov; 27(22):3578-3590. PubMed ID: 37605453
[TBL] [Abstract][Full Text] [Related]
2. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
Song J; Wei R; Huo S; Gao J; Liu X
Front Immunol; 2022; 13():920512. PubMed ID: 35769483
[TBL] [Abstract][Full Text] [Related]
3. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
4. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
6. Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis.
Gwee YX; Chia DKA; So J; Ceelen W; Yong WP; Tan P; Ong CJ; Sundar R
J Clin Oncol; 2022 Aug; 40(24):2830. PubMed ID: 35649219
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
[TBL] [Abstract][Full Text] [Related]
8. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients.
Gao J; Huo S; Zhang Y; Zhao Z; Pan H; Liu X
Cancer Med; 2023 Jan; 12(1):913-929. PubMed ID: 35621244
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of crucial lnc-TRIM28-14 and hub genes promoting gastric cancer peritoneal metastasis.
Dong C; Luan F; Tian W; Duan K; Chen T; Ren J; Li W; Li D; Zhi Q; Zhou J
BMC Cancer; 2023 Jan; 23(1):76. PubMed ID: 36690975
[TBL] [Abstract][Full Text] [Related]
10. Discovery of CDK signature and CDK5 as potential biomarkers for predicting prognosis and immunotherapeutic response in gastric cancer peritoneal metastases.
Sun Y; Chen Y; Cai Y; Wang X; Chen Q; Fang S; Lian M; Lv C; Weng J; Huang R; Zhuang W; Xue F; Cai L; Lin Y; Wang Q
Am J Cancer Res; 2023; 13(9):4087-4100. PubMed ID: 37818084
[TBL] [Abstract][Full Text] [Related]
11. Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis.
Huang XZ; Pang MJ; Li JY; Chen HY; Sun JX; Song YX; Ni HJ; Ye SY; Bai S; Li TH; Wang XY; Lu JY; Yang JJ; Sun X; Mills JC; Miao ZF; Wang ZN
Nat Commun; 2023 Feb; 14(1):822. PubMed ID: 36788228
[TBL] [Abstract][Full Text] [Related]
12. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
13. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
14. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
15. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer.
Zhang M; Cao C; Li X; Gu Q; Xu Y; Zhu Z; Xu D; Wei S; Chen H; Yang Y; Gao H; Yu L; Li J
Cancer Med; 2023 Jan; 12(2):2075-2088. PubMed ID: 35789544
[TBL] [Abstract][Full Text] [Related]
16. Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases.
Yang A; Zhang Z; Chaurasiya S; Park AK; Jung A; Lu J; Kim SI; Priceman S; Fong Y; Woo Y
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37019471
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome.
Chen Y; Cai G; Jiang J; He C; Chen Y; Ding Y; Lu J; Zhao W; Yang Y; Zhang Y; Wu G; Wang H; Zhou Z; Teng L
Gastric Cancer; 2023 Jul; 26(4):504-516. PubMed ID: 36930369
[TBL] [Abstract][Full Text] [Related]
18. Construction of a hypoxia-immune-related prognostic panel based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer.
Deng C; Deng G; Chu H; Chen S; Chen X; Li X; He Y; Sun C; Zhang C
Front Immunol; 2023; 14():1140328. PubMed ID: 37180146
[TBL] [Abstract][Full Text] [Related]
19. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of cuproptosis-related genes in prognosis, tumor microenvironment infiltration, and immunotherapy response in gastric cancer.
Nie H; Wang H; Zhang M; Ning Y; Chen X; Zhang Z; Hu X; Zhao Q; Chen P; Fang J; Wang F
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5453-5468. PubMed ID: 36462036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
